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Abstract
Toxicity screening of compounds provides a means to identify compounds harmful for human health and the environment.
Here, we further develop the technique of genomic phenotyping to improve throughput while maintaining specificity. We
exposed cells to eight different compounds that rely on different modes of action: four genotoxic alkylating (methyl
methanesulfonate (MMS), N-Methyl-N-nitrosourea (MNU), N,N9-bis(2-chloroethyl)-N-nitroso-urea (BCNU), N-ethylnitrosourea
(ENU)), two oxidizing (2-methylnaphthalene-1,4-dione (menadione, MEN), benzene-1,4-diol (hydroquinone, HYQ)), and two
non-genotoxic (methyl carbamate (MC) and dimethyl sulfoxide (DMSO)) compounds. A library of S. cerevisiae 4,852 deletion
strains, each identifiable by a unique genetic ‘barcode’, were grown in competition; at different time points the ratio
between the strains was assessed by quantitative high throughput ‘barcode’ sequencing. The method was validated by
comparison to previous genomic phenotyping studies and 90% of the strains identified as MMS-sensitive here were also
identified as MMS-sensitive in a much lower throughput solid agar screen. The data provide profiles of proteins and
pathways needed for recovery after both genotoxic and non-genotoxic compounds. In addition, a novel role for aromatic
amino acids in the recovery after treatment with oxidizing agents was suggested. The role of aromatic acids was further
validated; the quinone subgroup of oxidizing agents were extremely toxic in cells where tryptophan biosynthesis was
compromised.
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Introduction
The need to develop techniques to test toxicity of chemical
compounds is increasing. Ethical and legal considerations impose
constraints on animal usage for compound testing, making cell
culture based testing an attractive alternative. Toward this goal,
we and others have developed methods for genomic phenotyping,
a gene-by-gene genome-wide approach that provides mechanistic
detail on the modes of action of the test compound [1–9] (reviewed
in [10]). Routinely used tests such as the micronucleus test and
mouse lymphoma assays, are prone to false positives and provide
few indications of the mechanisms underlying the toxicity [11].
Further, cumbersome screens or methods prone to false positive
results stress the need to develop fast, sensitive techniques for drug
screening. We have previously optimized Saccharomyces cerevisiae
genomic phenotyping for liquid assays [9] and before that,
optimized the method for growth on solid agar [1,2]. We recently
showed that genomic phenotyping in yeast cells can be predictive
of toxicity-modulating proteins in human cells, increasing the
method’s relevance [12]. In this study, we demonstrate how high-
throughput parallel sequencing can be used to enhance the power
of genomic phenotyping [13–16].
Two of the major contributors to endogenous and exogenous
DNA damage are alkylating and oxidizing agents. A review on the
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cellular response to DNA damage caused by alkylating agents was
recently published by our group [17]. As for oxidative stress, cells
are exposed to environmental oxidants, but oxidative stress also
arises as a consequence of oxygen utilization for energy production
and other metabolic processes [18–20]. The major source for
reactive oxygen species (ROS) production is electrons leaked from
the respiratory complexes in mitochondria. ROS are also
generated by redox-active compounds such quinones and polycy-
clic aromatic hydrocarbons, which can be converted to redox-
active quinones by aldo-keto reductases [21]. When quinones are
reduced to semiquinones, superoxide (O2
–) is produced and
further reduction leads to hydroquinones and hydrogen peroxide
(H2O2) (reviewed in [22]). By redox cycling, the three quinone
products are kept in equilibrium [23]. Under normal conditions,
cellular antioxidant defenses are capable of neutralizing ROS [20].
However, when ROS exceed the antioxidant capacity, they react
with proteins, DNA, RNA, and lipids, which in turn may impair
cellular processes [19,20] resulting in general cell damage and
apoptosis [24]. ROS have been linked to numerous diseases,
particularly cancer, neurodegenerative diseases and premature
aging (reviewed in [25]).
In this study we exposed a library of 4,852 strains to eight
different compounds, genotoxic or non-genotoxic, alkylating or
oxidizing. The library of deletion strains were grown in
competition with each other and at different time points, the
ratio between the strains was assessed by quantitative ‘barcode’
sequencing. The results using this method produce toxicity profiles
that easily distinguish alkylating and oxidizing genotoxic com-
pounds from each other and from non-genotoxic compounds. In
addition, we show that toxicity profiles mirror previous results
obtained using much more cumbersome methods, and moreover,
revealed a novel role for aromatic amino acids in cellular
protection after ROS-inducing agents.
Results
Fast and Sensitive Method for Screening Agents
To determine differential growth patterns of strains deleted for
non-essential genes, cultures were made where close to equal
numbers of 4,852 deletion mutant strains were pooled and then
grown in competition. Each mutant has a strain-specific ‘barcode’
tag for identification. In different experiments, cultures was
exposed to eight compounds: methyl methanesulfonate (MMS),
N-methyl-N-nitrosourea (MNU), N,N9-bis(2-chloroethyl)-N-nitroso-
urea (BCNU), N-ethylnitrosourea (ENU), 2-methylnaphthalene-
1,4-dione (menadione, MEN), benzene-1,4-diol (hydroquinone,
HYQ), methyl carbamate (MC) and dimethyl sulfoxide (DMSO).
Seven of these compounds are carcinogens: the alkylating agents
MMS, MNU, BCNU and ENU, plus the oxidizing agents MEN
and HYQ; whereas MC is a non-genotoxic carcinogen. The
eighth compound, DMSO, was a control, which is neither
genotoxic nor carcinogenic (Table 1). Cultures were exposed to
4–5 doses for each agent. Exposure was chronic for 10 generation
times, as measured by increased OD595 for each individual
culture, at which point a sample was taken for sequencing. For the
remaining culture, growth media was exchanged with fresh media
without the test compound and the cells were grown for another
10 generation times to recover, after which a second sample was
taken for sequencing. After DNA extraction from each sample, the
representation of each strain was determined by Illumina high-
throughput sequencing of the strain-specific barcoded tags
(Figure 1A).
To determine the individual strain fitness, the sequencing data
was first filtered in several steps (Figure 1B): (i) by absolute number
of barcode sequence counts (.40); (ii) by fold change compared to
untreated control (abs(log2).1) for each dose; and (iii) by statistical
significance (Student’s t-test followed by Benjamini-Hochberg
False Discovery Rate (BH-FDR), BH-FDR ,0.05). Each
compound generated up to 230 sensitive strains (Table S1).
3,807 out of 4,994 strains (76%) passed the quality criteria of being
represented by at least 40 sequencing reads in at least one of the
untreated samples. 1,203 strains (32%) showed reduced fitness
when grown in at least one of the compounds (Table S2) and a
single strain (pol32D) was sensitive to all eight agents. The high
number of sensitive strains is expected given that almost all genes
are required under certain conditions [6]. There were few
differences between the growth for 10 or 20 generation times.
Genotoxic Agents have Different Profiles of Proteins
Needed for Survival
To group the agents by the gene products needed for cell
growth in the presence of that agent, we performed hierarchical
clustering of the fitness profiles. Strains that showed reduced fitness
to at least one of the compounds were included in the clustering
(Figure S1). The fitness so far was recorded as the log2 ratio
between exposed and unexposed cells. Here, the fitness was
summarized into a score representing the median of the log ratios
of the four-five doses for each compound. In parallel, we used two
groups, the entire set of 1,203 sensitive strains and a subset of 508
sensitive strains (Table S3). The smaller set used more stringent
selection criteria by limiting the input from each compound to a
maximum of 20 toxicity-modulating strains per dose, time-point
and replicate. This threshold was selected as the median number
of toxicity-modulating strains per data point was 23 (Figure S2). By
this method we achieve an easier overview of the data as well as
leveling the contributions of the different compounds and avoid a
clustering based on a single compound which might arise as a
technical artifact. Unsupervised hierarchical clustering of the
Figure 1. Experimental workflow for barcoded genomic
phenotyping. Schematic representation of A) experimental design (t
is the time of cell harvest, which was at 10 or 20 generation times) and
B) analysis and filtering of high-throughput sequencing data.
doi:10.1371/journal.pone.0073736.g001
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fitness scores revealed that, on the horizontal compound axis, the
main break in the clustering tree was created by alkylating (MNU,
ENU, MMS, BCNU) versus non-alkylating agents (Figure S1,
Figure 2A). Non-alkylating agents were further divided into
oxidizing (HYQ, MEN) and non-genotoxic (MC, DMSO) agents.
On the vertical strain axis of the stringent cluster (Figure 2A), four
main clusters were formed by the data-driven clustering (i-iv).
Cluster (i) deviated the most from the rest and was associated
specifically with reduced fitness after exposure to the four
alkylating agents. The largest cluster (iii) was comprised of strains
sensitive primarily to the oxidizing agents, whereas two clusters (ii,
iv) were associated with strains showing growth retardation after
exposure to non-genotoxic agents (Table S3). The 31 strains in
cluster (iv) have deletions of proteins implicated in a wide spectrum
of biological functions, including microtubule processing (Smy1,
She1, Jnm1, Num1, Bni1) and protein deubiquitination (Ubp2,
Ubp8, Sgf11).
To further characterize the strains, the protein-protein interac-
tions between the proteins that were absent in each of the sensitive
strains were mapped (Figure S3). The dense network of all proteins
leading to sensitivity when deleted was reduced by considering the
more stringent selection (Figure 2B). From the protein-protein
interaction networks of this set of strains with reduced fitness, we
identified seven interconnected components with more than five
nodes. The largest component with 19 nodes (Figure 2B1)
consisted of subunits of the ribosomal complex. The major
contribution came from proteins required for recovery upon
exposure to oxidizing agents, but some of these proteins also
contributed toward the recovery upon exposure to alkylating
agents. The second largest component with 17 nodes (Figure 2B2)
consisted almost exclusively of DNA repair proteins. In this
network, proteins required for recovery upon exposure to the
alkylating agents made up the entire cluster. For the four
remaining networks (Figure 2B3–7), contributions were for
recovery from both genotoxic and non-genotoxic compounds
and the functions represented were (broadly defined) cell cycle
regulation, metabolism, signaling and peroxisome organization.
Classification of Toxicity-modulating Proteins into
Functional Groups
To look for enrichment of functional categories among the
proteins that contribute to damage recovery, we analyzed the lists
with respect to gene ontology terms or KEGG pathways (Figure 3,
Table S4). The functional categories affected by the eight
compounds (FDR,0.05) can be divided into three subclusters:
(1) transport, (2) degradation/down regulation of biosynthesis, and
(3) DNA damage repair and cell cycle arrest (Figure 3). This third
cluster contains the most enriched subcluster composed of DNA
repair proteins needed for recovery upon exposure to the
alkylating agents MMS, MNU and ENU, and also a second
subcluster of cell cycle and DNA replication are required for
recovery from exposure to the same agents. Recovery from
exposure to oxidizing agents requires vesicle transport and
autophagy proteins to a higher degree compared to recovery
from alkylation damage.
In the initial phase, during the first 10 generation times (Table
S4), DNA repair and cell cycle-related GO or KEGG terms are
prevalent after treatment with genotoxic agents. For the non-
alkylating agents, the enriched GO terms involve vacuolar
transport and, surprisingly, for the oxidizing agents, phenylala-
nine, tyrosine and tryptophan biosynthesis are also represented.
The involvement of aromatic amino acid synthesis has not, to our
knowledge, previously been linked to the response to oxidative
stress.
In the recovery phase scored after 20 generation times (Table
S4), the MMS and MNU exposed strains lacking different aspects
of DNA repair continue to remain depleted whereas the strains
compromised for cell cycle control show increased representation.
Interestingly, the strains that only appear as having reduced fitness
in the recovery phase are largely involved in different aspects of
transport and relocalization of different cellular components.
Under the less stringent conditions (non-adjusted p,0.1) we re-
identify the biosynthesis of aromatic amino acids as influencing
recovery after exposure to the oxidizing agents MEN and HYQ.
The strains that showed altered growth in DMSO produced no
enriched GO terms at the higher significance level (FDR,0.05).
At lower stringency level (non-adjusted p,0.1) of the enrichment
(Tables S5 and S6), an expanded view can be seen.
Aromatic Amino Acids Specifically Required After ROS
Exposure
To validate the requirement for the biosynthesis of aromatic
amino acids, and especially tryptophan synthesis, for cells to
recover after oxidative genotoxic stress, we exposed five different
Table 1. List of selected compounds and doses used in this study.
Compound Abbreviation CAS number Group Dose (mM)
Methyl methanesulfonate MMS 66-27-3 Alkylating agent, genotoxic carcinogen 18.13, 36.32, 54.48,
72.64
N-Methyl-N-nitrosourea MNU 684-93-5 Alkylating agent, genotoxic carcinogen 0.48, 0.97, 1.46, 1.94
N-Ethyl-N-nitrosourea ENU 759-73-9 Alkylating agent, genotoxic carcinogen 1.708, 3.416, 5.124,
6.832
N,N9-bis(2-chloroethyl)-N-nitroso-urea BCNU 154-93-8 Alkylating agent, genotoxic, therapeutic
chemical
0.028, 0.056, 0.084,
0.112
2-Methylnaphthalene-1,4-dione
(Menadione)
MEN 58-27-5 Oxidizing agent, genotoxic, therapeutic
chemical
0.005, 0.010, 0.015,
0.020
Benzene-1,4-diol (Hydroquinone) HYQ 123-31-9 Oxidizing agent, genotoxic, therapeutic
chemical
18.164, 22.705,
27.245, 31.786
Methyl carbamate MC 598-55-0 Non-genotoxic carcinogen 0.028, 0.056, 0.084,
0.112
Dimethyl sulfoxide DMSO 67-68-5 Non-genotoxic, no carcinogen 0.5, 0.6, 0.7, 0.8, 0.9
doi:10.1371/journal.pone.0073736.t001
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strains lacking various components of the tryptophan biosynthesis
pathway to both ROS-generating (HYQ and MEN) and non-
ROS-generating (tBuOOH) oxidative stress (Figure 4). The
requirement for tryptophan synthesis turns out to be specific for
recovery upon exposure to the ROS-generating quinones/
hydroquinones (MEN, HYQ). Tryptophan synthesis does not
influence recovery from the differently acting oxidizing agent
tBuOOH. As controls we used cells lacking transcription factors
Skn7 and Yap1 that are needed for the transcription of oxidative
stress responsive genes [26]. As expected, the skn7 and yap1 strains
were sensitive to both quinone and non-quinone oxidizing agents.
Comparison with Previous Studies
To estimate the specificity and sensitivity of the barcode-
sequencing method described here we compared the MMS results
to those obtained in previous extensive genomic phenotyping
studies, both from our group on solid agar [2] and in liquid media
[9] and others [7,27]. Of the 48 strains that were associated with
reduced fitness upon exposure to MMS for 10 generation times in
this study, 43 (90%, p= 7610218 Fisher’s exact test) were also
identified as MMS sensitive when grown on solid agar. Among the
strains that showed a growth defect during the recovery phase (20
generation times), 147 of 226 (65%, p= 2610229) were identified
in the solid agar assay. In comparison with the genomic
phenotyping in liquid media, 24 of the strains (50%,
p= 1.4610212) identified at 10 generation times and 35 of the
strains identified at 20 generation times (15%, p= 0.006) in this
study were recovered in the previous results. These results indicate
that the specificity is high using the barcode-sequencing method.
As for the sensitivity, this method identified in total 240 strains
as MMS-sensitive, whereas in the solid agar assay, 1,455 strains
were identified as MMS sensitive [2] and in the liquid media assay,
479 strains were identified as MMS sensitive [9], giving a recovery
rate of 16% compared to the solid agar assay and 50% compared
to liquid media assay. However, when stratifying the data into
categories of different sensitivity, we note that of the most sensitive
strains in the solid agar screen (with a sensitivity score 30; see ref
[2]), 43% (13/30) are also identified using barcode-sequencing.
For the highly sensitive strains (score .20), 34% (26/76) are
recovered and for the strains with medium sensitivity (score
between 11 and 20), 25% (48/195) are recovered. Only for the
strains showing low sensitivity in the solid agar screen (score #10)
is the recovery rate poor, as only 7.4% (88/1184) of the strains are
identified using the barcode-sequencing approach.
Comparison with data from other groups also shows consistency
between results. Among the proteins causing MMS-sensitivity
when deleted, 73% (35/48) are also found in study from the
Parsons et al [7], and from an earlier study from Chang et al [27],
38% (18/48) are re-found in the list of proteins needed for MMS
resistance. The lower concordance with the latter study, is
consistent with a similarly low recovery between these two studies,
38% (39 out of 102) MMS-sensitive strains from Parsons et al [7]
are also identified in Chang et al [27].
Together, the data from these comparisons indicate that the
barcode-sequencing method identifies toxicity-modulating pro-
teins with high confidence.
Figure 2. The difference between alkylating and oxidizing agents can be explained by fitness profiles of the strains. A) Two-
dimensional hierarchical clustering of fitness ratio (median log ratio of exposed/control) results using the strains sensitive after 10 and 20 generation
times upon exposure to different chemicals. Compounds and doses are plotted across the horizontal axis. On the vertical axis, a subset of 508 strains
with reduced fitness is shown. B) Protein-protein interaction networks with.5 toxicity-modulating proteins. The colors (explained in legend, same as
labels in A) within the pie charts indicate the contribution of each of the eight compounds. Alkylating agents represented in shades of yellow-red,
oxidizing agents in shades of blue and non-genotoxic compounds in green.
doi:10.1371/journal.pone.0073736.g002
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Discussion
Here we present a screening method for drug toxicity with data
for eight compounds. The technique separates out different subsets
of proteins needed for cellular recovery upon exposure to a range
of genotoxic and non-genotoxic compounds. This study targets a
problem that faces pharmaceutical and other industries requiring
early indicators of the genotoxic effects of a test compound. The
solid agar genomic phenotyping previously developed [1,2],
provided a sensitive and robust method to screen a library of
eukaryotic cells with a test compound in order to ascertain
whether the compound is toxic and if so by what mechanism.
However, the method uses individually grown cultures of each
mutant strain and is too cumbersome to be a technically feasible
approach for systematic screening of large numbers of compounds.
The method presented here provides a realistic alternative, with
maintained specificity, although with a lower sensitivity.
The results presented in this study provide comprehensive
profiles of the proteins required for cellular recovery after exposure
to a range of alkylating, oxidizing and also non-genotoxic
compounds. Many of the identified toxicity-modulating proteins
and pathways, such as the DNA repair cluster needed after
alkylating agent treatment, have already been heavily studied [28].
However, novel pathways needed for recovery also came to light,
such as the requirement of aromatic amino acid synthesis
(reviewed in [29]) following exposure to the oxidizing agents
menadione (MEN) and hydroquinone (HYQ). Amino acid uptake
or synthesis has previously been implicated in survival after a
variety of compounds [30–33]. A question that remains unan-
swered is, what is the role of aromatic amino acid synthesis in
cellular recovery specifically after quinone exposure? It has been
reported that charge transfer can occur between semiquinones and
the aromatic amino acids tyrosine and tryptophan [34]. Possibly,
the funneling of unpaired electrons to the free aromatic acids acts
as a scavenger for oxygen radicals produced by the quinone/
hydroquinone redox cycling [35,36]. It was previously known that
the transcriptional profile of H2O2 and MEN exposed cells are
largely similar [37]. Genes, such as superoxide dismutases,
glutathione peroxidases, and thiol-specific antioxidants, involved
in the detoxification of both H2O2 and O2
2 are strongly induced
after exposure. The majority of these genes are under control of
the Yap1 and Skn7 transcription factors [38]. However, the Skn7
and Yap1 proteins are also activated in the response to tBuOOH,
suggesting that the tryptophan synthesis is induced under a
different system.
As the details of the DNA damage response are being
elucidated, it is becoming evident that many pathways other than
Figure 3. Functional enrichment reveals an alkylating agent-specific DNA repair and cell cycle dependency. Gene-annotation
enrichment analysis heat map and clustering for sensitive strains to different compounds at early (10 generation times) or late (20 generation times)
timepoints. Heat map colors correspond to the –log10 of the p-values.
doi:10.1371/journal.pone.0073736.g003
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DNA repair and cell cycle checkpoints are involved in cellular
recovery after exposure to DNA damaging agents [1,2,9,12]. At
the time of damage, several different sets of proteins are needed for
a plethora of functions to deal with several different kinds of
molecular damage, but once the cell has dealt with that damage,
the cell reinitiates the cell cycle, requiring another set of proteins.
Some genes, such as the environmental stress response (ESR)
genes [37], are transcriptionally regulated independently of the
stressor. Expression of many other genes is stressor specific.
Among the 868 ESR proteins, 23 (8%) were identified in this
study, indicating that the toxicity-modulating proteins identified by
genomic phenotyping complements the results from expression
profiling.
In conclusion, while further developing a higher throughput
method for toxicity screening, we have discovered that biosynthe-
sis of aromatic amino acids, and specifically tryptophan synthesis,
provides protection from quinone/hydroquinone-induced ROS in
eukaryotic cells.
Materials and Methods
Reagents
Test componds were purchased from Sigma-Aldrich: MMS
(Cat #129925), MNU (Cat #N4766), menadione (Cat #M5625),
hydroquinone (Cat #240125), methyl carbamate (Cat #246352),
DMSO (Cat #D2650), BCNU (Cat #C0400), ENU (Cat
#N8509).
Deletion Pool Construction, Cell Culture, and Sample
Preparation
Pools of the yeast haploid deletion collection were prepared as
described previously [13]. The deletion pools were cultured at
30uC and 250 rpm in an incubator shaker using YPD media
(10 g/l yeast extract, 20 g/l peptone, 20 g/l dextrose) containing
100 mg/ml G418. To prepare sequencing samples, we followed
the protocol as described previously [14,39]. DNA was isolated
using YeaStar genomic DNA kit (ZymoResearch Inc, Irvine CA).
Barcodes were PCR-amplified and the resulting PCR-fragments
were sequenced at the BioMicroCenter at MIT.
Sequence Data Processing
Analysis was performed similarly to as previously described
[40]. Samples were sequenced on a Solexa Genome Analyzer 2.0,
generating single ends reads of 35 nucleotides. The first four bases
comprise the multiplexing code used to assign each read to an
experiment and a sample (five total for each experiment: one of
four sorted fractions or the original pool). The next set of bases
identify whether the read corresponds to an uptag or downtag
barcode, and the final 14 bases (13 for uptags) provides sufficient
information to uniquely identify the barcode [14]. Custom Matlab
scripts parse sequencing reads to tabulate the number of perfect
Figure 4. Tryptophan biosynthesis rescues cells from ROS. A) A schematic of the tryptophan biosynthesis pathway [29]. PRA: N-(59-
phospohribosyl)-anthsranilate, CDRP: 1-(o-carboxyphenylamino)-1-desoxyribuose-5-phosphate. B) Compound sensitivity of selected mutant strains
were analyzed by spot assay. Strains were grown in liquid YPD+G418 overnight at 30uC and then diluted in YPD. Ten-fold serial dilutions of each yeast
culture was spotted onto YPD plates in the absence (control) and presence of the different compounds: MMS (0.006%), MEN (40 mM), HYQ (3 mg
ml21), and tBuOOH (0.75 mM). Plates were incubated at 30uC and growth was recorded after 48 h exposure.
doi:10.1371/journal.pone.0073736.g004
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barcode reads for each strain in each sample, and for each
experiment.
The tabulated counts for each strain were normalized to a
frequency for each sample as to compare frequencies in the
exposed cultures to the frequencies in the original (unexposed)
pool. These frequencies are calculated separately for uptags and
downtags, as well as for each independent experiment (i.e. each
screen has two independent replicates, so that there are four
separate frequency vectors for each sample in each screen).
Because each sample contains strains for which few or no barcodes
are detected, a baseline value of 10 counts was added to each
vector of frequencies to eliminate spurious hits arising from poorly
represented strains. The raw counts were quantile-normalized and
then treated/control ratio was log-transformed (base 2).
Data Analysis
Custom scripts were written in R. Cluster and Treeview [41],
Cytoscape [42], GoogleCharts was used for visualization. Raw
data is deposited at SRA with accession number SRA091991.
Supporting Information
Figure S1 Two-dimensional hierarchical clustering of
fitness ratio (median log ratio of exposed/control)
results using the strains sensitive after 10 and 20
generation times upon exposure to different chemicals.
Compounds and doses are plotted across the horizontal axis. On
the vertical axis, the 1,203 strains with reduced fitness are shown.
(TIF)
Figure S2 Histogram of number of sensitive strains for
each data point (in total 160). Red hashed line indicates the
median number (23) of strains at each data point.
(TIF)
Figure S3 Protein-protein interaction network of all
1,203 toxicity-modulating strains.
(TIF)
Table S1 Growth retarded strains.
(XLSX)
Table S2 Log ratio (treated/control) of growth retarded
strains (all).
(XLSX)
Table S3 Log ratio (treated/control) of growth retarded
strains (top 20).
(XLSX)
Table S4 Enriched gene sets after 10 and 20 generation
times (stringent criteria, FDR,0.05).
(XLSX)
Table S5 Enriched gene sets after 10 generation times
(complete lists).
(XLSX)
Table S6 Enriched gene sets after 20 generation times
(complete lists).
(XLSX)
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